Wearable Injectors and Connected Devices Conference 2019

Wearable Injectors and Connected Devices Conference 2019

SMi Group 09/10/2019 to 10/10/2019 | United Kingdom, Copthorne Tara Hotel London Kensington

The global wearable devices market size is expected to reach a value of $12.1 billion USD by 2021 with time dependent delivery, large volume administration with minimal injection pain and the use of connectivity to enhance user-value being key factors driving the market.

With this in mind, the conference will explore new technologies and advances of on-body devices for the administration of viscous and large molecule drug delivery, and evaluate the impact of IoT, connectivity and enhancement of user-interface, which make up core components within the wearable devices field.

BENEFITS OF ATTENDING:• LISTEN to case studies from leading pharmaceutical companies revolutionising the medical device industry• HEAR how on-body injectors are facilitating the administration of time-dependent, large volume and viscous drug delivery• ASSESS how connectivity is being used to improve patient adherence, health-monitoring and enhancing the user-interface• EXPLORE the compatibility, pain and patient handling considerations projecting wearable devices as the future of drug delivery

Join us in October 2019 to have the opportunity to network with Global Device Development Managers, Senior Connectivity Engineers, Leaders in Device Data Generation, Human Factors Directors and many more!

PLUS TWO INTERACTIVE PRE-CONFERENCE WORKSHOPSTuesday 8th October 2019 Cross company collaboration to develop digital therapeutic solutions using connected devicesWorkshop Leader: Digby Harris, Global Category Manager – Digital Therapeutics & Devices, AstraZeneca

Wearable injectors: Envisioning their evolution to address current and future unmet needsWorkshop Leader: James Blakemore, Senior Consultant, Cambridge ConsultantsWorkshop Leader: Sergio Marlorni, Senior Consultant, Cambridge Consultants

page up